SPECIAL NOTICE
65 -- Notice of Intent to Sole Source--POLYSERP�, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom
- Notice Date
- 8/3/2022 7:25:20 PM
- Notice Type
- Special Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH22R0083
- Response Due
- 8/19/2022 7:00:00 AM
- Point of Contact
- Toloria DuVall
- E-Mail Address
-
toloria.s.duvall.civ@mail.mil
(toloria.s.duvall.civ@mail.mil)
- Description
- The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a sole source contract under the authority of FAR 13.106(b)(1) � Soliciting from a single source for purchases not exceeding the simplified acquisition threshold and only one source is reasonably available, on or about 19 August 2022 to CRO, LLC, 516 E. Spruce St., Missoula, MT 59802 under NAICS 325414 Biological Product (except Diagnostics) Manufacturing. The US Army Medical Materiel Development Activity (USAMMDA) Force Health Protection (FHP) Directorate has a requirement for: one (1) shipment of Polyvalent F(ab�)2 Immunoglobulin Fragments (Equine), Snake Antivenom for multiple African nations. See attachment for details.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/cd23dd97753d48f287272ef81126f357/view)
- Record
- SN06412187-F 20220805/220803230109 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |